Spots Global Cancer Trial Database for cancer of the lung
Every month we try and update this database with for cancer of the lung cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma | NCT02549638 | Carcinoma, Squa... Carcinoma, Squa... Squamous Cell C... Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | DNA Extraction | 18 Years - | Mayo Clinic | |
| Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer | NCT00365183 | Non-Small Cell ... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer | NCT00365183 | Non-Small Cell ... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung | NCT03603652 | Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Carcinoma, Non-... Non-Small Cell ... Non-Small-Cell ... | Microwave Ablat... | 18 Years - | Ethicon, Inc. | |
| Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer | NCT02410603 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
| A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | NCT03157128 | Non-Small Cell ... Medullary Thyro... Colon Cancer Any Solid Tumor | LOXO-292 | 12 Years - | Eli Lilly and Company | |
| A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
| A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
| Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer | NCT02250326 | Carcinoma, Non-... | nab-paclitaxel ... CC-486 Duravalumab | 18 Years - | Celgene | |
| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma | NCT02549638 | Carcinoma, Squa... Carcinoma, Squa... Squamous Cell C... Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | DNA Extraction | 18 Years - | Mayo Clinic | |
| Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation | NCT00716157 | Cancer of the H... Cancer of the L... Cancer of the E... Gastro-esophage... | 18 Years - | Thomas Jefferson University | ||
| Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer | NCT02027428 | Squamous Cell C... | Abraxane (Induc... Carboplatin (In... Abraxane (Maint... Best Supportive... Abraxane (Induc... Carboplatin (In... Best Supportive... | 18 Years - | Celgene | |
| Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer | NCT00129844 | Adenocarcinoma Non-Small-Cell ... Lung Neoplasms | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System | NCT02370303 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
| A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System | NCT02370303 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
| Investigating the Improvement in 4D CT Images Using AV Biofeedback | NCT00780611 | Cancer of the L... Abdominal Cance... | 18 Years - 86 Years | University of Maryland, Baltimore | ||
| LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy | NCT00328588 | Lung Cancer Cancer of Lung Cancer of the L... Non-Small Cell ... Carcinoma, Non-... | YM155 | 18 Years - | Astellas Pharma Inc | |
| Breath Test for Early Detection of Lung Cancer | NCT00639067 | Lung Neoplasms | Breath Collecti... | 18 Years - | Menssana Research, Inc. | |
| Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer | NCT05132075 | Non-Small Cell ... | JDQ443 docetaxel | 18 Years - | Novartis | |
| Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC) | NCT00431015 | Lung Cancer | IPI-504 | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
| Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation | NCT00716157 | Cancer of the H... Cancer of the L... Cancer of the E... Gastro-esophage... | 18 Years - | Thomas Jefferson University | ||
| The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study | NCT01785537 | Cardiovascular ... Chronic Obstruc... Cancer of the L... Cancer of the B... Cancer of the S... | 30 Years - 80 Years | Università degli Studi 'G. d'Annunzio' Chieti e Pescara | ||
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
| Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer | NCT05132075 | Non-Small Cell ... | JDQ443 docetaxel | 18 Years - | Novartis | |
| Microwave Ablation in Chinese Patients With Lung Tumors | NCT04889989 | Cancer of the L... | Microwave Ablat... | 18 Years - | Ethicon, Inc. | |
| MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) | NCT02673021 | Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Metastatic Canc... | Microwave ablat... | 18 Years - | Mayo Clinic | |
| Breath Test for Early Detection of Lung Cancer | NCT00639067 | Lung Neoplasms | Breath Collecti... | 18 Years - | Menssana Research, Inc. | |
| Microwave Ablation in Chinese Patients With Lung Tumors | NCT04889989 | Cancer of the L... | Microwave Ablat... | 18 Years - | Ethicon, Inc. | |
| Investigating the Improvement in 4D CT Images Using AV Biofeedback | NCT00780611 | Cancer of the L... Abdominal Cance... | 18 Years - 86 Years | University of Maryland, Baltimore | ||
| Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer | NCT00129844 | Adenocarcinoma Non-Small-Cell ... Lung Neoplasms | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer | NCT01545947 | Carcinoma, Non-... Non-Small Cell ... | CC-223, erlotin... CC-223, oral az... CC-223, oral az... | 18 Years - | Celgene | |
| Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation | NCT04699188 | KRAS G12C Mutan... Carcinoma, Non-... Carcinoma, Colo... Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | JDQ443 TNO155 tislelizumab | 18 Years - | Novartis | |
| NEUWAVE Flexible Probe Study #2 | NCT03713099 | Cancer of the L... Lung Cancer Neoplasms, Lung Carcinoma, Non-... Non-Small Cell ... Non-Small Cell ... | Microwave ablat... | 18 Years - | Ethicon, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
